The KRT10 gene helps make keratin 10, a protein that gives strength to the outer layers of your skin as skin cells mature. This gene plays an important role in keeping the skin barrier sturdy and able to handle everyday friction. If it does not work properly, the skin may be more fragile, with blistering, redness, and later thickened, scaly areas. Pathogenic variants in the KRT10 gene are linked to a skin condition called epidermolytic ichthyosis.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes hold the information needed to make proteins, the parts of cells that do much of the work. Others mainly help determine when certain processes happen, where they happen, and how strongly they operate. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can find more in the LearnHub.
Overview
KRT10Gene function
What if the gene works
The KRT10 gene helps make keratin 10, a protein that gives the outer skin layers strength and structure. It supports normal skin cell maturation and helps the skin barrier stay stable.
Risk
What if the gene does not work
Variants in the KRT10 gene can cause epidermolytic ichthyosis, a skin condition that often brings fragile, blistering skin at birth and later thicker, scaly skin. Milder and more severe variants can affect when features appear and how extensive they are.
Treatment
What does that mean for your treatment
For epidermolytic ichthyosis linked to variants in the KRT10 gene, oral retinoids such as acitretin or isotretinoin can reduce scaling and thickened skin. Many people with variants in the KRT10 gene respond better to retinoids than those with KRT1-related disease. These medicines are used cautiously because they can also increase skin fragility and blistering, so treatment is tailored to symptoms and tolerance.
Conditions associated with KRT10
Gene function
What if the gene works
Your outer skin depends on the KRT10 gene to handle rubbing, stretching, and everyday wear. It provides instructions for keratin 10, a protein used mainly by skin cells as they mature in the upper layer of skin. This helps explain how the KRT10 gene supports the skin barrier in daily life.
KRT10 helps build tough fibers inside maturing skin cells in the upper layer of skin. These fibers act like an internal framework, helping cells keep their shape during everyday movement and friction.
Keratin 10 joins with keratin 1 to form strong fiber networks inside skin cells. Working as a pair gives the outer skin layers the firmness they need for daily protection.
As skin cells move upward, the KRT10 gene becomes part of their normal maturation program. It helps cells shift from active growth to a more protective role at the surface.
By strengthening the upper skin layers, this gene helps the skin barrier hold in moisture and limit entry of everyday irritants. That steady barrier function matters when your skin faces dry air, washing, and rubbing.
What is a variant?
A genetic variant is a minor difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. At times, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
KRT10 gene variants can change the keratin 10 protein so it cannot join properly with neighboring keratins, weakening the inner support network of upper skin cells. This is how KRT10 gene variants affect skin cell structure, and stronger changes often disrupt that network more than milder ones. Changes in key joining regions are often linked to earlier, more noticeable epidermolytic ichthyosis, while some shortening variants misdirect the protein into the nucleus, as seen in ichthyosis with confetti.
How variants are linked to conditions
Pathogenic variants in the KRT10 gene cause inherited skin conditions, most notably epidermolytic ichthyosis and a rarer condition called ichthyosis with confetti. In daily life, KRT10 gene changes linked to skin disease can show up as widespread redness and blistering early on, followed by thicker, scaly skin, while certain specific variants lead to many small spots of normal-looking skin appearing over time. These findings can confirm a genetic diagnosis rather than simply showing a higher risk.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common throughout the general population. Most have no direct effect on health and are simply part of natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For KRT10, the main risk is set by whether you carry a disease-causing gene change, often inherited in a family. Heat, rubbing or friction, and skin infections can make skin problems more noticeable or severe. There is not enough evidence to say that lifestyle changes lower the underlying genetic risk.
Inheritance of KRT10 variants
KRT10-related skin conditions are usually inherited in an autosomal dominant pattern, which means one altered copy of the KRT10 gene is enough to cause the condition. If a parent carries a disease-causing variant, each child has a 50% chance of inheriting it. The KRT10 inheritance pattern also includes new, de novo variants, so some people are the first in their family to have the condition. Because KRT10 is on chromosome 17, people of any sex can inherit it and pass it on.
What does my KRT10 result mean for my family?
A disease-causing change in the KRT10 gene is usually passed down in a dominant way, so close relatives such as a parent, sibling, or child may also carry the same change and could have similar skin symptoms, even if those symptoms are milder. Each child of someone with a KRT10-related skin condition may have a 1 in 2, or 50%, chance of inheriting it. Some cases happen for the first time in one person and are not inherited from either parent.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for the KRT10 gene usually uses a blood or saliva sample to read the gene and look for variants linked to certain inherited skin conditions. In how to test for KRT10 variants, a lab compares your DNA sequence with the usual KRT10 pattern and reports whether a relevant variant was found.
When should I consider getting a genetic test?
Consider testing the KRT10 gene if someone has had skin blistering from birth or early infancy, followed by thick, rough, scaly skin, or if this pattern runs in the family. Testing can help confirm the cause and clarify the chance of passing it on.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, though how much it reveals depends on the condition and on the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or reacts to it at its target. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in some people.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that looks at how genetic differences affect the response to medications. It examines relationships between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed and more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the KRT10 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so general questions about symptoms, treatment side effects, or medication choices are best discussed with your doctor.
History
Doctors had described families with thick, fragile skin for many years before the KRT10 gene was tied to a specific inherited skin condition. In the late 1980s and early 1990s, researchers identified keratin genes as key players in these patterns, and KRT10 soon emerged as one of the important discoveries. Initially understood only through visible traits, later recognized as tied to a specific gene, this shift helped move skin medicine from description to molecular diagnosis. From these first observations, research expanded steadily. Studies of KRT10 and related keratin genes helped explain why some skin conditions run in families and why they can look similar but have different genetic causes. This work remains part of the foundation of modern inherited skin disease research.